Trends in breast cancer survival in Germany from 1976 to 2008-A period analysis by age and stage

Cancer Epidemiology

Volumn 35, Issue 5, 2011, Pages 399-406

  Holleczek, Bernd ^a   Arndt, Volker ^b   Stegmaier, Christa ^a   Brenner, Hermann ^b  

^a SAARLAND CANCER REGISTRY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Breast cancer; Population based cancer registry; Screening; Survival; Treatment

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; GERMANY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREND STUDY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; GERMANY; HUMANS; INCIDENCE; MIDDLE AGED; MORTALITY; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 80052953792     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.01.008     Document Type: Article

References (42)

1. Ferlay J., Parkin D.M., Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010, 46(4):765-781.
2. Botha J.L., Bray F., Sankila R., Parkin D.M. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003, 39(12):1718-1729.
3. Berry D.A., Cronin K.A., Plevritis S.K., Fryback D.G., Clarke L., Zelen M., et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, 353(17):1784-1792.
4. Elmore J.G., Armstrong K., Lehman C.D., Fletcher S.W. Screening for breast cancer. JAMA 2005, 293(10):1245-1256.
5. Sant M., Allemani C., Berrino F., Coleman M.P., Aareleid T., Chaplain G., et al. Breast carcinoma survival in Europe and the United States. Cancer 2004, 100(4):715-722.
6. Gondos A., Bray F., Hakulinen T., Brenner H. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol 2009, 20(3):564-573.
7. Gondos A., Arndt V., Holleczek B., Stegmaier C., Ziegler H., Brenner H. Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer 2007, 121(2):395-400.
8. Sant M., Allemani C., Capocaccia R., Hakulinen T., Aareleid T., Coebergh J.W., et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003, 106(3):416-422.
9. Siesling S., van de Poll-Franse L.V., Jobsen J.J., Repelaer van Driel O.J., Voogd A.C. Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990-2001. Breast 2007, 16(6):606-614.
10. Bouchardy C., Rapiti E., Fioretta G., Laissue P., Neyroud-Caspar I., Schafer P., et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003, 21(19):3580-3587.
11. Janssen-Heijnen M.L., Maas H.A., Houterman S., Lemmens V.E., Rutten H.J., Coebergh J.W. Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer 2007, 43(15):2179-2193.
12. Ederer F., Axtell L.M., Cutler S.J. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961, 6:101-121.
13. Esteve J., Benhamou E., Raymond L. Statistical methods in cancer research. Descriptive epidemiology 1994, vol. IV. IARC Sci Publ., Lyon.
14. Coale A.J., Kisker E.E. Defects in data on old-age mortality in the United States: new procedures for calculating schedules and life tables at the higher ages. Asian Pac Popul Forum 1990, 4:1-31.
15. Tabeau E., van den Berg Jeths A., Heathcote C. Forecasting mortality in developed countries 2001, Springer Netherlands, Dordrecht.
16. Ederer F., Heise H. Instructions to IBM 650 programmers in processing survival computations 1959, National Cancer Institute, Bethesda (MD).
17. Brenner H., Gefeller O., Hakulinen T. Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004, 40(3):326-335.
18. Brenner H., Soderman B., Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 2002, 31(2):456-462.
19. Talback M., Stenbeck M., Rosen M. Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish Cancer Registry data. Eur J Cancer 2004, 40(9):1361-1372.
20. Brenner H., Rachet B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 2004, 40(16):2494-2501.
21. Brenner H., Arndt V., Gefeller O., Hakulinen T. An alternative approach to age adjustment of cancer survival rates. Eur J Cancer 2004, 40(15):2317-2322.
22. Corazziari I., Quinn M., Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004, 40(15):2307-2316.
23. Greenwood M. A report on the natural duration of cancer 1926, HM Stationery Office, London.
24. Pokhrel A., Dyba T., Hakulinen T. A Greenwood formula for standard error of the age-standardised relative survival ratio. Eur J Cancer 2008, 44(3):441-447.
25. Brenner H., Hakulinen T. Up-to-date and precise estimates of cancer patient survival: model-based period analysis. Am J Epidemiol 2006, 164(7):689-696.
26. Brenner H., Hakulinen T. Model based hybrid analysis of cancer patient survival. Eur J Cancer 2007, 43(5):921-927.
27. Holleczek B., Gondos A., Brenner H. PeriodR-an R package to calculate long-term cancer survival estimates using period analysis. Methods Inf Med 2009, 48(2):123-128.
28. Sant M., Allemani C., Santaquilani M., Knijn A., Marchesi F., Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009, 45(6):931-991.
29. Ernster V.L., Barclay J., Kerlikowske K., Grady D., Henderson C. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996, 275(12):913-918.
30. Barchielli A., Federico M., De Lisi V., Bucchi L., Ferretti S., Paci E. In situ breast cancer: incidence trend and organised screening programmes in Italy. Eur J Cancer 2005, 41(7):1045-1050.
31. Virnig B.A., Tuttle T.M., Shamliyan T., Kane R.L. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 2010, 102(3):170-178.
32. Glass A.G., Lacey J.V., Carreon J.D., Hoover R.N. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 2007, 99(15):1152-1161.
33. Ravdin P.M., Cronin K.A., Howlader N., Berg C.D., Chlebowski R.T., Feuer E.J., et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007, 356(16):1670-1674.
34. Katalinic A., Lemmer A., Zawinell A., Rawal R., Waldmann A. Trends in hormone therapy and breast cancer incidence-results from the German Network of Cancer Registries. Pathobiology 2009, 76(2):90-97.
35. Gondos A., Holleczek B., Arndt V., Stegmaier C., Ziegler H., Brenner H. Trends in population-based cancer survival in Germany: to what extent does progress reach older patients?. Ann Oncol 2007, 18(7):1253-1259.
36. Vercelli M., Capocaccia R., Quaglia A., Casella C., Puppo A., Coebergh J.W. Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group. Crit Rev Oncol Hematol 2000, 35(3):161-179.
37. Lavelle K., Todd C., Moran A., Howell A., Bundred N., Campbell M. Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or=65 years. Br J Cancer 2007, 96(8):1197-1203.
38. Passage K.J., McCarthy N.J. Critical review of the management of early-stage breast cancer in elderly women. Intern Med J 2007, 37(3):181-189.
39. Elkin E.B., Bach P.B. Cancer's next frontier: addressing high and increasing costs. JAMA 2010, 303(11):1086-1087.
40. Warren J.L., Yabroff K.R., Meekins A., Topor M., Lamont E.B., Brown M.L. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst 2008, 100(12):888-897.
41. Brenner H., Stegmaier C., Ziegler H. Estimating completeness of cancer registration: an empirical evaluation of the two source capture-recapture approach in Germany. J Epidemiol Community Health 1995, 49(4):426-430.
42. Feinstein A.R., Sosin D.M., Wells C.K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985, 312(25):1604-1608.